Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Methylprednisolone × Clear all

NCT00003682 2016-06-23

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms